hydroxychloroquine sulfate (ARD-1300) / Pulmoquine - LARVOL DELTA

Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19. (PubMed, Pharmaceutics) - "The emitted doses ranged from 9.1 to 75.9 mg, depending on the concentration and volume nebulised. The HCQS solutions appear suitable for preclinical and clinical studies for potential COVID-19 treatment."

Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

New clinical trials bring potential COVID-19 treatments to North Texas (The Dallas Morning News) - '"I recognize that sometimes it may feel uncomfortable to sign up for a trial in which you may be assigned to a placebo,' said Dr. Mamta Jain...who is running the hospital’s clinical trials for COVID-19 treatments. 'It’s important for us to very rigorously look at drug A and B and C and compare it to what we currently have-which is basically nothing- and see if it really works.' She added that trial volunteers are heroes because 'they really help us to find better treatments for everyone.'"

Audio • Media quote • Novel Coronavirus Disease

US “Corona 19, two’generic drugs’ catch“ [Google translation] - "Prof. Russell Buhr...said, 'Therapies such as hydroxychloroquine should be administered only in hospitals with critical care specialists.'"

Media quote • Novel Coronavirus Disease

Coronavirus patient’s recovery after 20 days on ventilator is a miracle for family, a welcome boost for doctors - "At UCLA Health, where more than a dozen studies related to COVID-19 are ongoing, Dr. Russell Buhr...said success stories such as Zuniga's give doctors everywhere a dose of encouragement. For Buhr, who said he looks at new studies every day that are coming out at record speed, it's still too early to predict with any certainty which patients will recover and which will not. 'We're studying all of this stuff,' he said....Buhr cautioned that the benefit to harm ratio is still largely unknown for a drug such as chloroquine....'We always run the risk of harming someone,' Buhr said."

Media quote • Novel Coronavirus Disease

Lessons learned: COVID-19 survival rates higher because of treatments - "In March and April, patients with COVID-19 symptoms arriving at hospitals were on average more severely ill than those arriving in recent months, making their odds at survival lower, said Dr. Sarun Thomas...Many people who were sick but unsure if they had COVID-19 avoided hospitals as long as possible for fear of contracting the coronavirus there, Thomas said."

Media quote • Novel Coronavirus Disease

Can hydroxychloroquine prevent COVID-19? Bad press getting in the way of KU finding out - '"It had a definite negative impact,' said pulmonologist Mario Castro, the study’s principal investigator at the KU site and vice chair for clinical and translational research at the University of Kansas School of Medicine....'That’s one of the things that HERO has been combating, is that there’s very little prophylaxis information' about hydroxychloroquine, Castro said. 'We are hoping now…that we’ll be able to answer this definitely with an adequate sample size'....'Again, that’s part of the confusion in the public, Castro said."

Media quote • Novel Coronavirus Disease